Orforglipron (development codes LY3502970) is an oral, non-peptide, small molecule glucagon-like peptide-1 (GLP-1) receptor agonist for adult obesity and type 2 diabetes .
As a GLP-1 receptor agonist, its primary mechanism of action involves enhancing glucose-dependent secretion and improving energy balance . A key advantage of Orforglipron over many existing GLP-1 therapies is its oral administration, which offers greater convenience compared to injectable alternatives and could improve patient compliance .
| Product Name | Orforglipron |
| CAS NO. | 2212025-52-3 |
| Appearance | White powder |
| Purity | 98% HPLC |
| Application | Research peptides |
| Shelf Life | 24 Months |
| Storage | Store at a temperature of 2-8 degrees, protected from light. |